MARKET

EVFM

EVFM

Evofem Bioscienc
OTCMQB
0.012
-0.001
-9.38%
Opening 15:39 11/08 EST
OPEN
0.014
PREV CLOSE
0.013
HIGH
0.014
LOW
0.012
VOLUME
137.60K
TURNOVER
1.81K
52 WEEK HIGH
196.25
52 WEEK LOW
0.0060
MARKET CAP
1.16M
P/E (TTM)
-0.0236
1D
5D
1M
3M
1Y
5Y
1D
ADITXT PROVIDES UPDATE ON EQUITY LINE OF CREDIT, ATM USAGE, AND OUTSTANDING NUMBER OF SHARES
Reuters · 7h ago
Evofem Biosciences Gains Support for Aditxt Merger
TipRanks · 2d ago
Aditxt announces Evofem secures voting agreements with investors for merger
TipRanks · 2d ago
*Evofem Biosciences Secured Voting Agreements With Certain of Investors to Ensure They Will Vote in Favor of Merger Proposal
Dow Jones · 2d ago
Press Release: Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
Dow Jones · 2d ago
Press Release: Evofem Secures Investor Support for Proposed Merger through Voting Agreements
Dow Jones · 2d ago
EVOFEM SECURES INVESTOR SUPPORT FOR PROPOSED MERGER THROUGH VOTING AGREEMENTS
Reuters · 2d ago
Weekly Report: what happened at EVFM last week (1028-1101)?
Weekly Report · 4d ago
More
About EVFM
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is commercializing advanced products to address unmet needs in women’s sexual and reproductive health. Its first FDA-approved product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Phexxi is an advanced gel that works to prevent pregnancy without the use of hormones. Phexxi prevents pregnancy by reducing sperm motility, inhibiting sperm from reaching the ovum to form a zygote. Phexxi is designed to address underserved and unmet needs in the birth control market. Using its platform, women can have a telehealth visit with a health care provider to determine their eligibility for a Phexxi prescription. It is also focused on commercializing SOLOSEC (secnidazole) 2g oral granules that address two pervasive sexual health infections.

Webull offers Evofem Biosciences Inc stock information, including OTCMQB: EVFM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVFM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EVFM stock methods without spending real money on the virtual paper trading platform.